Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 3
1998 7
1999 3
2000 2
2001 5
2002 1
2003 4
2004 4
2005 4
2006 4
2007 8
2008 7
2009 11
2010 7
2011 10
2012 9
2013 8
2014 6
2015 4
2016 3
2018 4
2019 5
2020 2
2021 5
2022 13
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 24912652

125 results

Results by year

Filters applied: . Clear all
Page 1
Changes over time in the relationship between symptoms of asthma, rhinoconjunctivitis and eczema: a global perspective from the International Study of Asthma and Allergies in Childhood (ISAAC).
Asher MI, Stewart AW, Wong G, Strachan DP, García-Marcos L, Anderson HR; ISAAC Phase Three Study Group. Asher MI, et al. Allergol Immunopathol (Madr). 2012 Sep-Oct;40(5):267-74. doi: 10.1016/j.aller.2011.11.004. Epub 2012 Jan 31. Allergol Immunopathol (Madr). 2012. PMID: 22297190
Antibiotic use in infancy and symptoms of asthma, rhinoconjunctivitis, and eczema in children 6 and 7 years old: International Study of Asthma and Allergies in Childhood Phase III.
Foliaki S, Pearce N, Björkstén B, Mallol J, Montefort S, von Mutius E; International Study of Asthma and Allergies in Childhood Phase III Study Group. Foliaki S, et al. J Allergy Clin Immunol. 2009 Nov;124(5):982-9. doi: 10.1016/j.jaci.2009.08.017. J Allergy Clin Immunol. 2009. PMID: 19895986
The burden of asthma, hay fever and eczema in children in 25 countries: GAN Phase I study.
García-Marcos L, Asher MI, Pearce N, Ellwood E, Bissell K, Chiang CY, El Sony A, Ellwood P, Marks GB, Mortimer K, Martínez-Torres AE, Morales E, Perez-Fernandez V, Robertson S, Rutter CE, Silverwood RJ, Strachan DP; Global Asthma Network Phase I Study Group. García-Marcos L, et al. Eur Respir J. 2022 Sep 15;60(3):2102866. doi: 10.1183/13993003.02866-2021. Print 2022 Sep. Eur Respir J. 2022. PMID: 35144987 Free PMC article. Clinical Trial.
Worldwide time trends in prevalence of symptoms of rhinoconjunctivitis in children: Global Asthma Network Phase I.
Strachan DP, Rutter CE, Asher MI, Bissell K, Chiang CY, El Sony A, Ellwood E, Ellwood P, García-Marcos L, Marks GB, Morales E, Mortimer K, Pearce N, Pérez-Fernández V, Robertson S, Silverwood RJ; Global Asthma Network Phase I Study Group. Strachan DP, et al. Pediatr Allergy Immunol. 2022 Jan;33(1):e13656. doi: 10.1111/pai.13656. Epub 2021 Sep 21. Pediatr Allergy Immunol. 2022. PMID: 34453861 Free PMC article.
Comparison of individual-level and population-level risk factors for rhinoconjunctivitis, asthma, and eczema in the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three.
Rutter CE, Silverwood RJ, Asher MI, Ellwood P, Pearce N, Garcia-Marcos L, Strachan DP; ISAAC Phase Three Study Group. Rutter CE, et al. World Allergy Organ J. 2020 Jul 2;13(6):100123. doi: 10.1016/j.waojou.2020.100123. eCollection 2020 Jun. World Allergy Organ J. 2020. PMID: 32642022 Free PMC article.
125 results